Moore Capital Management, LP Scholar Rock Holding Corp Transaction History

Moore Capital Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$6.02 - $7.76 $331,100 - $426,800	55,000 Added 531.2%	65,354 $464,000
Q2 2023 Aug 14, 2023	BUY	$5.79 - $9.11 $59,949 - $94,324	10,354 New	10,354 $78,000
Q4 2020 Feb 16, 2021	SELL	$13.72 - $51.57 $1.37 Million - $5.16 Million	-100,000 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$9.63 - $17.14 $337,050 - $599,900	-35,000 Reduced 25.93%	100,000 $1.21 Million
Q4 2019 Feb 14, 2020	BUY	$7.2 - $13.2 $252,000 - $462,000	35,000 Added 35.0%	135,000 $1.78 Million
Q3 2019 Nov 14, 2019	BUY	$8.95 - $15.72 $894,999 - $1.57 Million	100,000 New	100,000 $895,000

175

75.6M

585K

862K

Ticker SRRK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,640,600
Market Cap $2.17B
Description
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...

Get notified when there are updates to the investment portfolio of Moore Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Moore Capital Management, LP with notifications on news.